Company Overview

Claritev Corporation (NYSE: CTEV), formerly known as MultiPlan Corporation, is a healthcare technology, data analytics, and cost-management company that provides software, network-based solutions, and payment integrity services to healthcare payers, employers, government entities, and other healthcare stakeholders. The company operates primarily in the U.S. healthcare services and healthcare information technology industries, with a focus on reducing medical costs, improving pricing transparency, and supporting claims processing efficiency. Its principal revenue drivers include network-based medical cost management, data and analytics services, payment integrity solutions, and platform-based healthcare administration technologies.

Claritev evolved from MultiPlan’s long-standing role as a healthcare cost-management provider founded in 1980. Over several decades, the company expanded through acquisitions, platform development, and partnerships with insurers and healthcare payers. In 2024, the company rebranded to Claritev as part of a broader strategic repositioning centered on data-driven healthcare affordability, transparency, and technology-enabled workflow solutions. The company’s market positioning is supported by extensive provider network relationships, large-scale healthcare claims datasets, and long-term contractual relationships with major commercial health insurers and self-funded employer plans.

Business Operations

Claritev organizes its operations around healthcare cost-management and technology-enabled services, including Network-Based Services, Analytics and Payment Integrity Solutions, and healthcare data management offerings. The company generates revenue primarily through transaction-based fees, savings-based arrangements tied to healthcare claim reductions, software-enabled services, and recurring client contracts with health plans and employers. Its solutions are designed to identify claim savings opportunities, improve pricing accuracy, and streamline healthcare payment workflows across commercial and government healthcare markets.

The company’s operations are concentrated in the United States, though some technology and support functions have international components. Claritev controls substantial healthcare claims databases, proprietary analytics platforms, provider network assets, and workflow automation technologies used by insurers and healthcare administrators. Strategic relationships with large national and regional health insurers form a core component of its operating model. The company has historically expanded capabilities through acquisitions and technology integrations, including assets associated with data analytics and payment integrity functions.

Strategic Position & Investments

Claritev’s strategic direction emphasizes healthcare affordability, data intelligence, and technology modernization. The company has focused on expanding its analytics capabilities, enhancing automation in claims review processes, and improving interoperability across healthcare payment systems. Management has also emphasized growth in value-added technology services and broader adoption of platform-driven healthcare cost management solutions. The rebranding from MultiPlan to Claritev reflected a strategic effort to reposition the company beyond traditional network discounting into a broader healthcare technology and insights platform.

Historically, the company has pursued acquisitions and investments intended to strengthen healthcare analytics, payment integrity, and data aggregation capabilities. Claritev continues investing in artificial intelligence-enabled claims analysis, large-scale healthcare data processing, and workflow automation technologies designed to support payers and self-funded employers. The company’s portfolio includes proprietary healthcare pricing datasets and technology infrastructure that support medical reimbursement analysis, out-of-network pricing tools, and fraud, waste, and abuse detection initiatives. Public disclosures indicate continued investment in scalable technology infrastructure and enterprise platform integration.

Geographic Footprint

Claritev is headquartered in McLean, Virginia, and primarily operates across the United States healthcare market. The company maintains relationships with national and regional health insurers, third-party administrators, employers, and government-related healthcare entities throughout the country. Its provider network and claims management services reach healthcare participants across all major U.S. regions.

Although its principal commercial activities are U.S.-focused, Claritev maintains certain operational and technology functions with international support capabilities. Its influence in healthcare payments and cost-management infrastructure is tied largely to its extensive domestic payer relationships and nationwide provider connectivity. The company’s solutions are integrated into large-scale healthcare claims workflows affecting millions of covered individuals through commercial and government-sponsored healthcare programs.

Leadership & Governance

Claritev’s leadership team has emphasized operational transformation, healthcare affordability, technology modernization, and long-term client integration strategies. The company operates under a public company governance framework following its public market listing and subsequent corporate restructuring initiatives. Management communications and public filings have highlighted a focus on improving operational efficiency, expanding analytics-driven offerings, and strengthening client retention through integrated healthcare technology solutions.

Key executives include:

• Travis Dalton – Chief Executive Officer
• Mark Taber – Chief Financial Officer
• Patrick Linehan – Executive Vice President and Chief Legal Officer
• Steven J. Solomon – Chairman of the Board
• Jeffrey Liebman – President, Payment and Revenue Integrity

The company’s governance structure includes oversight by a board of directors responsible for strategic direction, financial controls, and regulatory compliance consistent with publicly traded healthcare technology companies. Public filings and investor materials indicate continued emphasis on technology-enabled growth, operational discipline, and healthcare cost transparency initiatives.